ARTFL LEFFTDS Longitudinal Frontotemporal Dementia Study (ALLFTD)

Brief description of study

The purpose of this study (ALLFTD) is to understand how Frontotemporal Lobar Degeneration (FTLD) syndromes progress over time, and to develop new tools to help with diagnosis and eventual treatment. The study is enrolling patients with FTLD syndromes. Additionally, the study is enrolling healthy members of families where there is a strong family history of FTLD or known FTLD-associated genetic mutation. Participating in the longitudinal arm of ALLFTD involves annual visits to an ALLFTD clinical site. These visits usually span 2-3 days, and involve a neurological exam; tests of memory, behavior, and judgement; a blood draw, imaging of your brain (MRI), and a lumbar puncture (LP). All participants enrolled in ALLFTD will have their DNA (from the blood draw) tested for FTLD-associated genetic mutations.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Frontotemporal Dementia
Age: Between 30 Years - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 842595

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).